The inhibition of CK2, important for the maintenance of cancer stem cells, was also directly implicated in the reduction in self-renewal capability of HeLa sphere-forming cells by apigenin, while downregulation of survival and proliferation factors was accounted for by the sensitisation of CD44+ prostate cancer stem cells to cisplatin [165]. The gene discussed is CD44; the disease is cancer.